ATE134989T1 - N-trityl asparaginsäurederivate zur herstellung von phosphonat nmda antagonisten - Google Patents

N-trityl asparaginsäurederivate zur herstellung von phosphonat nmda antagonisten

Info

Publication number
ATE134989T1
ATE134989T1 AT92921774T AT92921774T ATE134989T1 AT E134989 T1 ATE134989 T1 AT E134989T1 AT 92921774 T AT92921774 T AT 92921774T AT 92921774 T AT92921774 T AT 92921774T AT E134989 T1 ATE134989 T1 AT E134989T1
Authority
AT
Austria
Prior art keywords
trityl
acid derivatives
nmda antagonists
asparagic acid
producing
Prior art date
Application number
AT92921774T
Other languages
English (en)
Inventor
Jeffrey P Whitten
Duane E Rudisill
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of ATE134989T1 publication Critical patent/ATE134989T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT92921774T 1991-11-15 1992-10-13 N-trityl asparaginsäurederivate zur herstellung von phosphonat nmda antagonisten ATE134989T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79283491A 1991-11-15 1991-11-15

Publications (1)

Publication Number Publication Date
ATE134989T1 true ATE134989T1 (de) 1996-03-15

Family

ID=25158215

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92921774T ATE134989T1 (de) 1991-11-15 1992-10-13 N-trityl asparaginsäurederivate zur herstellung von phosphonat nmda antagonisten

Country Status (16)

Country Link
EP (1) EP0613459B1 (de)
JP (1) JP3168563B2 (de)
KR (1) KR100241480B1 (de)
AT (1) ATE134989T1 (de)
AU (1) AU667845B2 (de)
CA (1) CA2121835A1 (de)
DE (1) DE69208888T2 (de)
DK (1) DK0613459T3 (de)
ES (1) ES2087555T3 (de)
FI (1) FI942248A0 (de)
GR (1) GR3019587T3 (de)
HU (1) HU214055B (de)
IL (1) IL103710A (de)
MX (1) MX9206448A (de)
NO (1) NO305314B1 (de)
WO (1) WO1993010075A1 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2025326C (en) * 1989-09-19 2001-04-24 Jeffrey P. Whitten Nmda antagonists

Also Published As

Publication number Publication date
MX9206448A (es) 1993-05-01
IL103710A0 (en) 1993-04-04
NO305314B1 (no) 1999-05-10
NO941820L (no) 1994-05-13
GR3019587T3 (en) 1996-07-31
HU214055B (en) 1997-12-29
EP0613459B1 (de) 1996-03-06
EP0613459A1 (de) 1994-09-07
HUT70551A (en) 1995-10-30
FI942248A7 (fi) 1994-05-13
CA2121835A1 (en) 1993-05-27
DE69208888T2 (de) 1996-08-01
WO1993010075A1 (en) 1993-05-27
DE69208888D1 (de) 1996-04-11
FI942248L (fi) 1994-05-13
JPH07501523A (ja) 1995-02-16
IL103710A (en) 1998-02-08
AU2864292A (en) 1993-06-15
KR100241480B1 (ko) 2000-03-02
JP3168563B2 (ja) 2001-05-21
AU667845B2 (en) 1996-04-18
HU9401469D0 (en) 1994-08-29
FI942248A0 (fi) 1994-05-13
ES2087555T3 (es) 1996-07-16
NO941820D0 (no) 1994-05-13
DK0613459T3 (da) 1996-04-01

Similar Documents

Publication Publication Date Title
DE69233790D1 (de) Verfahren zur Herstellung von Fullerenen
DE68919053D1 (de) Verfahren zur Herstellung von Aluminoxanen.
DE69233519D1 (de) Verfahren zur Herstellung von Aerosolzusammensetzungen
DE69011739D1 (de) Verfahren zur Herstellung von Phosphatidsäure.
NO914002L (no) Fremgangsmaate for fremstilling av mettede hydroxyalkylkinolinsyrer som leukotrienantagonister
DE69106586D1 (de) Verwendung von Baclofen zur Herstellung von Arzneimitteln zur Behandlung von Angina pectoris.
DE59208629D1 (de) Verfahren zur Herstellung von 1,1,1,2,3,3,3-Heptafluorpropan (R 227)
DE69228330D1 (de) Verfahren zur Herstellung von Waschmittelzusammensetzungen
DE69010294D1 (de) Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs.
ATE111734T1 (de) Verfahren zur herstellung von direktkomprimierten, cephalosporansäure derivate enthaltendentabletten.
DE69901519D1 (de) Verfahren zur Herstellung von 2,2'-bis (Hydroxymethyl)alkansäure
DE69220708D1 (de) Verfahren zur Herstellung von 2,2,6,6,-Tetramethyl-4-Amino-Piperidilen
DE69202419D1 (de) Verfahren zur Herstellung von Fulleren.
DE59306642D1 (de) Verfahren zur Herstellung von Calcium-L-ascorbat-2-phosphat
DE58906606D1 (de) Optisch aktive Rhodiumkomplexe von 3,4-Bis(diarylphosphino)-pyrrolidinen und ihre Verwendung zur Herstellung von Phosphinothricin durch asymmetrische Hydrierung.
DE68921787D1 (de) Verfahren zur Herstellung von N-Phosphonomethylglycin.
DE69208888D1 (de) N-trityl asparaginsäurederivate zur herstellung von phosphonat nmda antagonisten
ATE247474T1 (de) Verwendung von inosittriphosphat zur herstellung von arzneimitteln
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
DE58908978D1 (de) Verfahren zur Herstellung von Pigmentzusammensetzungen.
DE59105908D1 (de) Verfahren zur Herstellung von Bis(hydroxymethyl)phosphinaten.
DE59003418D1 (de) Verfahren zur Herstellung von reinen C4-C7-tert.-Alkenen.
DE69007362D1 (de) Verfahren zur Herstellung von staubfreiem Natriumdithionit.
DE59104571D1 (de) Verfahren zur Herstellung von Vinylphosphonsäurederivaten.
DE69200795D1 (de) Verfahren zur Herstellung von L-Prolinederivaten.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee